Co-Authors
This is a "connection" page, showing publications co-authored by SHREYASKUMAR PATEL and KELLY K HUNT.
Connection Strength
0.463
-
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma. Nat Cancer. 2024 Apr; 5(4):625-641.
Score: 0.059
-
Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol. 2003 Aug 15; 21(16):3092-7.
Score: 0.057
-
Tumor volume as a prognostic factor for sarcomatosis. Cancer. 2002 May 01; 94(9):2441-6.
Score: 0.052
-
Phase II study of neoadjuvant checkpoint blockade in patients with surgically resectable undifferentiated pleomorphic sarcoma and dedifferentiated liposarcoma. BMC Cancer. 2018 Sep 24; 18(1):913.
Score: 0.041
-
Phase 1 adaptive dose-finding study of neoadjuvant gemcitabine combined with radiation therapy for patients with high-risk extremity and trunk soft tissue sarcoma. Cancer. 2015 Oct 15; 121(20):3659-67.
Score: 0.033
-
Surgical resection of gastrointestinal stromal tumors after treatment with imatinib. Ann Surg Oncol. 2007 Jan; 14(1):14-24.
Score: 0.018
-
Retroperitoneal soft tissue sarcoma: an analysis of radiation and surgical treatment. Int J Radiat Oncol Biol Phys. 2007 Jan 01; 67(1):158-63.
Score: 0.018
-
Angiosarcoma of the breast. Cancer. 2005 Dec 15; 104(12):2682-8.
Score: 0.017
-
A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res. 2004 Sep 01; 64(17):5913-9.
Score: 0.015
-
Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas. J Clin Oncol. 2004 Aug 15; 22(16):3375-80.
Score: 0.015
-
Interval between surgery and radiotherapy: effect on local control of soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1461-7.
Score: 0.015
-
Is there a role for surgery in patients with "unresectable" cKIT+ gastrointestinal stromal tumors treated with imatinib mesylate? Am J Surg. 2003 Dec; 186(6):665-9.
Score: 0.015
-
Radiographic response to neoadjuvant chemotherapy is a predictor of local control and survival in soft tissue sarcomas. Cancer. 2002 Sep 01; 95(5):1120-6.
Score: 0.013
-
Extraosseous osteosarcoma: response to treatment and long-term outcome. J Clin Oncol. 2002 Jan 15; 20(2):521-7.
Score: 0.013
-
Cost-effectiveness of staging computed tomography of the chest in patients with T2 soft tissue sarcomas. Cancer. 2002 Jan 01; 94(1):197-204.
Score: 0.013
-
Concurrent ifosfamide-based chemotherapy and irradiation. Analysis of treatment-related toxicity in 43 patients with sarcoma. Cancer. 2001 Sep 15; 92(6):1550-5.
Score: 0.013
-
Utility of chest computed tomography for staging in patients with T1 extremity soft tissue sarcomas. Cancer. 2001 Aug 15; 92(4):863-8.
Score: 0.012
-
Alveolar soft part sarcoma: clinical course and patterns of metastasis in 70 patients treated at a single institution. Cancer. 2001 Feb 01; 91(3):585-91.
Score: 0.012
-
Impact of neoadjuvant chemotherapy on postoperative morbidity in soft tissue sarcomas. J Clin Oncol. 2000 Oct 01; 18(19):3378-83.
Score: 0.012
-
Long-term outcome of patients with American Joint Committee on Cancer stage IIB extremity soft tissue sarcomas. J Clin Oncol. 1999 Sep; 17(9):2772-80.
Score: 0.011
-
Patterns of recurrence in extremity liposarcoma: implications for staging and follow-up. Cancer. 1999 Jan 01; 85(1):85-92.
Score: 0.010